
浏览全部资源
扫码关注微信
1.230601 合肥,安徽医科大学第二附属医院:肾脏内科
2.230011 合肥,合肥市第五人民医院血液净化中心
3.230601 合肥,安徽医科大学第二附属医院:检验科
[闫军放, E-mail: yanjunfanggood@163.comYAN Junfang, E-mail: yanjunfanggood@163.com
收稿:2024-05-20,
修回:2024-07-30,
纸质出版:2024-09-30
移动端阅览
闫军放, 宗茜, 袁亮, 等. 甲状旁腺全切+自体移植术对肾性继发性甲状旁腺功能亢进患者骨密度的影响[J]. 陆军军医大学学报, 2024,46(18):2152-2157.
Junfang YAN, Qian ZONG, Liang YUAN, et al. Effect of total parathyroidectomy with autotransplantation on bone mineral density in patients with renal secondary hyperparathyroidism[J]. Journal of Army Medical University, 2024, 46(18): 2152-2157.
闫军放, 宗茜, 袁亮, 等. 甲状旁腺全切+自体移植术对肾性继发性甲状旁腺功能亢进患者骨密度的影响[J]. 陆军军医大学学报, 2024,46(18):2152-2157. DOI: 10.16016/j.2097-0927.202405072.
Junfang YAN, Qian ZONG, Liang YUAN, et al. Effect of total parathyroidectomy with autotransplantation on bone mineral density in patients with renal secondary hyperparathyroidism[J]. Journal of Army Medical University, 2024, 46(18): 2152-2157. DOI: 10.16016/j.2097-0927.202405072.
目的
2
观察甲状旁腺全切+自体移植术(total parathyroidectomy with autotransplantation
tPTx+AT)对继发性甲状旁腺功能亢进(secondary hyperparathyroidism
SHPT)患者骨密度(bone mineral density,BMD)及血清可溶性Klotho(soluble Klotho
sKlotho)蛋白的影响。
方法
2
选取自2019年6月至2022年5月于安徽医科大学第二附属医院行tPTx+AT患者86例,收集患者术前人口学特征,术前及术后第5天、术后1个月、术后3个月、术后6个月、术后12个月及术后24个月的血清校正钙、磷、全段甲状旁腺激素(intact parathyroid hormone
iPTH)、碱性磷酸酶(alkaline phosphatase
ALP)、成纤维细胞生长因子23(fibroblast growth factor 23
FGF23)及sKlotho蛋白,双能X线吸收法测量术前及术后(3个月、6个月、12个月及24个月)腰椎L1-L4骨密度。观察tPTx+AT术前及术后FGF23、sKlotho蛋白及骨密度的变化。
结果
2
86例患者均手术成功,术后临床症状如骨痛、皮肤瘙痒等明显改善;术后血钙、磷、iPTH、ALP及FGF23较术前均明显下降。血sKlotho在术后第5天时较术前显著下降,术后1个月时sKlotho水平较术前升高约24.5%,此后sKlotho趋于稳定。术后腰椎L1-L4骨密度增加,至术后12个月最高。进一步分析显示,透析龄、SHPT持续时间、ALP、iPTH及FGF23与术前腰椎L1-L4 Z值呈负相关,sKlotho与术前腰椎L1-L4 Z值呈正相关。
结论
2
tPTx+AT可显著改善SHPT患者临床症状,调节钙磷代谢平衡,增加sKlotho、降低FGF23水平,是提高骨密度的有效治疗手段。
Objective
2
To investigate the impact of total parathyroidectomy with autotransplantation (tPTx+AT) on bone mineral density and serum soluble Klotho (sKlotho) level in patients with secondary hyperparathyroidism (SHPT).
Methods
2
A total of 86 patients undergoing tPTx+AT in the Second Affiliated Hospital of Anhui Medical University from June 2019 to May 2022 were recruited in this study. Their demographic characteristics were collected before surgery
along with serum levels of corrected calcium
phosphorus
intact parathyroid hormone (iPTH)
alkaline phosphatase (ALP)
fibroblast growth factor 23 (FGF23)
and sKlotho before and at 5 d
and 1
3
6
12 and 24 months after surgery. Dual energy X-ray absorptiometry was used to determine the BMD values of the lumbar spine L1-L4 before surgery and at 3
6
12 and 24 months after surgery. The changes in BMD and serum FGF23 and sKlotho levels before and after tPTx+AT were observed.
Results
2
Surgical treatment was successfully completed in all 86 patients
with their clinical symptoms such as bone pain and skin itching significantly improved postoperatively
and markedly decreased serum calcium
phosphorus
iPTH
ALP and FGF23 levels. The sKlotho level was significantly lower at 5 d postoperatively than that preoperatively
with that at 1 month after surgery increased by approximately 24.5% than the preoperative level
and then the level was in a stable trend. The BMD values at the lumbar spine L1-L4 were increased postoperatively
and reached the highest levels at 12 months postoperatively. Further analyses showed that dialysis vintage
duration of SHPT
and ALP
iPTH and FGF23 levels were negatively correlated with the Z-scores of the lumbar spine L1-L4
while sKlotho level was positively correlated with the Z-scores.
Conclusion
2
tPTx+AT can significantly improve the clinical symptoms of SHPT patients
regulate the balance of calcium and phosphorus metabolism
increase sKlotho level and reduce FGF23 level. It is an effective method to improve BMD.
GBD CHRONIC KIDNEY DISEASE COLLABORATION. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2020, 395 (10225): 709-733. DOI: 10.1016/S0140-6736(20)30045-3.
DI IORGI N, MARUCA K, PATTI G, et al . Update on bone density measurements and their interpretation in children and adolescents[J ] . Best Pract Res Clin Endocrinol Metab, 2018, 32(4): 477-498. DOI: 10.1016/j.beem.2018.06.002.
SATO M, INABA M, YAMADA S, et al . Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study[J ] . J Bone Miner Metab, 2021, 39(6): 1082-1090. DOI: 10.1007/s00774-021-01253-y.
KOMABA H, KALUDJEROVIC J, HU D Z, et al . Klotho expression in osteocytes regulates bone metabolism and controls bone formation[J ] . Kidney Int, 2017, 92(3): 599-611. DOI: 10.1016/j.kint.2017.02.014.
贺青卿, 田文. 慢性肾脏病继发甲状旁腺功能亢进外科临床实践中国专家共识(2021版)[J]. 中国实用外科杂志, 2021, 41(8): 841-848. DOI: 10.19538/j.cjps.issn1005-2208.2021.08.01.
HE Q Q, TIAN W. Chinese expert consensus on surgical practice of hyperthyroidism in patients with chronic kidney disease(2021 edition)[J]. Chin J Pract Surg, 2021, 41(8): 841-848. DOI: 10.19538/j.cjps.issn1005-2208.2021.08.01.
CHÁVEZ K V, MÁRQUEZ-GONZÁLEZ H, CHAVEZ-TOSTADO M. The usefulness of intraoperative PTH as a predictor for successful parathyroidectomy in secondary hyperparathyroidism[J]. Front Surg, 2021, 8: 696469. DOI: 10.3389/fsurg.2021.696469.
ZHANG L N, XING C Y, SHEN C, et al . Diagnostic accuracy study of intraoperative and perioperative serum intact PTH level for successful parathyroidectomy in 501 secondary hyperparathyroidism patients[J ] . Sci Rep, 2016, 6: 26841. DOI: 10.1038/srep26841.
SLOUMA M, SAHLI H, BAHLOUS A, et al . Mineral bone disorder and osteoporosis in hemodialysis patients[J ] . Adv Rheumatol, 2020, 60(1): 15. DOI: 10.1186/s42358-020-0118-0.
HASHIMOTO H, SHIKUMA S, MANDAI S, et al . Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients[J ] . Sci Rep, 2021, 11(1): 1648. DOI: 10.1038/s41598-021-81287-4.
赵丹丹, 戴仲方, 孙嘉遥, 等. 维持性血液透析患者血清鸢尾素水平与腰椎骨密度的相关性[J]. 中国血液净化, 2022, 21(11): 808-812. DOI: 10.3969/j.issn.1671-4091.2022.11.005.
ZHAO D D, DAI Z F, SUN J Y, et al . Correlation between serum irisin level and lumbar bone mineral density in maintenance hemodialysis[J ] . Chin J Blood Purif, 2022, 21(11): 808-812. DOI: 10.3969/j.issn.1671-4091.2022.11.005.
MALLUCHE H H, MAWAD H W, MONIER-FAUGERE M C. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients[J]. J Bone Miner Res, 2011, 26(6): 1368-1376. DOI: 10.1002/jbmr.309.
白成丽, 杨洁. 维持性血液透析患者甲状旁腺素与腰椎骨密度的关联[J]. 中国老年学杂志, 2024, 44(6): 1378-1382.
BAI C L, YANG J. Correlation between parathyroid hormone and lumbar bone mineral density in maintenance hemodialysispatients[J]. Chin J Gerontol, 2024, 44(6): 1378-1382.
中华医学会放射学分会骨关节学组, 中国医师协会放射医师分会肌骨学组, 中华医学会骨科学分会骨质疏松学组, 等. 骨质疏松的影像学与骨密度诊断专家共识[J]. 中国骨质疏松杂志, 2020, 26(9): 1249-1256. DOI: 10.3969/j.issn.1006-7108.2020.09.001.
Bone and Joint Group of Chinese Society of Radiology, Chinese Medical Association, Musculoskeletal Radiology Society of Chinese MedicalDoctOrs Association, Osteoporosis Group of Chinese orthopedic Association, Chinese Medical Association, et al . Consensus on the diagnosis of osteoporosis by imaging and bone mineral density measurement[J ] . Chin J Osteoporos, 2020, 26(9): 1249-1256. DOI: 10.3969/j.issn.1006-7108.2020.09.001.
YENCHEK R H, IX J H, SHLIPAK M G, et al . Bone mineral density and fracture risk in older individuals with CKD[J ] . Clin J Am Soc Nephrol, 2012, 7(7): 1130-1136. DOI: 10.2215/CJN.12871211.
YAJIMAA, OGAWA Y, TAKAHASHI H E, et al . Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism[J ] . Am J Kidney Dis, 2003, 42(4): 729-738. DOI: 10.1016/s0272-6386(03)00909-0.
YAMANOUCHI M, UBARA Y, HAYAMI N, et al . Bone mineral density 5 years after parathyroidectomy in hemodialysis patients with secondary hyperparathyroidism[J ] . Clin Nephrol, 2013, 79(5): 380-386. DOI: 10.5414/CN107661.
SUZUKI H, AMIZUKA N, ODA K, et al . Histological and elemental analyses of impaired bone mineralization in klotho-deficient mice[J ] . J Anat, 2008, 212(3): 275-285. DOI: 10.1111/j.1469-7580.2008.00859.x.
SHIMADA T, KAKITANI M, YAMAZAKI Y, et al . Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism [J ] . 2004, 113(4): 561-568. DOI: 10.1172/JCI19081 http://dx.doi.org/10.1172/JCI19081 ..
MILOVANOVA L Y, LYSENKO KOZLOVSKAYA L V, MILOVANOVA S Y, et al . Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2-5D[J ] . Ter Arkh, 2020, 92 (6): 37-45. DOI: 10.26442/00403660.2020.06.000670.
WEI X, HUANG X Y, LIU N, et al . Understanding the stony bridge between osteoporosis and vascular calcification: impact of the FGF23/klotho axis[J ] . Oxid Med Cell Longev, 2021, 2021: 7536614. DOI: 10.1155/2021/7536614.
YAMASHITA T, YOSHITAKE H, TSUJI K, et al . Retardation in bone resorption after bone marrow ablation in klotho mutant mice[J ] . Endocrinology,2000, 141(1): 438-445. DOI: 10.1210/endo.141.1.7252.
AHMADI R, HAJIALILO M, GHORBANIHAGHJO A, et al . FGF-23, klotho and vitamin D levels in Scleroderma [J ] . Iran J Public Health, 2017, 46(4): 530-536..
ZHENG S B, CHEN Y, ZHENG Y, et al . Correlationof serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients[J ] . Eur J Med Res, 2018, 23(1): 18. DOI: 10.1186/s40001-018-0315-z.
陶永亮. 血清FGF-23和Klotho蛋白水平与尿毒症患者骨密度的相关性研究[J]. 中国骨质疏松杂志, 2019, 25(9): 1244-1247, 1256. DOI: 10.3969/j.issn.1006-7108.2019.09.009.
TAO Y L. Correlation between serum FGF-23 andKlotho protein levels and bone mineral density in uremic patients[J]. Chin J Osteoporos, 2019, 25(9): 1244-1247, 1256. DOI: 10.3969/j.issn.1006-7108.2019.09.009.
HU M C, SHI M J, MOE O W. Role of αKlotho and FGF23 in regulation of type Ⅱ Na-dependent phosphate co-transporters[J]. Pflugers Arch, 2019, 471(1): 99-108. DOI: 10.1007/s00424-018-2238-5.
TAKAHASHI H, KOMABA H, TAKAHASHI Y, et al . Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism[J ] . 2014, 99(4): E652-E658. DOI: 10.1210/jc.2013-4050 http://dx.doi.org/10.1210/jc.2013-4050 ..
RHEE Y, BIVI N, FARROW E, et al . Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo [J ] . Bone, 2011, 49(4): 636-643. DOI: 10.1016/j.bone.2011.06.025..
KOMABA H, LANSKE B. Role ofKlotho in bone and implication for CKD[J]. Curr Opin Nephrol Hypertens, 2018, 27(4): 298-304. DOI: 10.1097/MNH.0000000000000423.
0
浏览量
89
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621